Search

Your search keyword '"Tao, Qing-Feng"' showing total 22 results
Start Over Author "Tao, Qing-Feng"
22 results on '"Tao, Qing-Feng"'

6. Effect of different non-pharmacological placebo treatments for migraine: a network meta-analysis of randomized controlled trials

Author

Zheng, Hui, Tao, Qing Feng, Xiao, Xin Yu, Wang, Xiao Ying, Feng, Si Jia, Huang, Yanbing, and Yuanlu

Subjects
Medical Sciences, sham, migraine attack numbers, non-pharmacologic therapies, sham acupuncture, sham Cognitive Behavioral Therapy(CBT), placebo treatment, sham transcranial Direct Current Stimulation(tDCS), Medical Specialties, Medicine and Health Sciences, migraine days, migraine, sham repetitive Transcranial Magnetic Stimulation(rTMS), sham non-invasive Vagus Nerve Stimulation(nVNS), network meta-analysis
Abstract

Do placebo treatment of different non-pharmacologic therapies on migraine patients in randomized controlled trials have therapeutic effects? What is the degree of these effect？Which placebo has the better non-specific effect？

Published
2023
Full Text
View/download PDF

8. Acupuncture for irritable bowel syndrome: Study protocol of a prospective, multicentre, registry study in real-world settings

Author

Shi, Yun-zhou, primary, Ye, Kun, additional, Chen, Min, additional, Xie, Xin, additional, Fan, Xi-yi, additional, Xie, Chao-rong, additional, Tao, Qing-feng, additional, Hua, Can, additional, Wu, Qin-ping, additional, Jiang, Xiao-han, additional, Wan, Yu-ying, additional, Li, Zhi-gang, additional, Zheng, Hui, additional, and Yu, Shu-guang, additional

Published
2022
Full Text
View/download PDF

21. A Sensitive NaKATPase Assay Specific for Inhibitors Acting Through the DigitalisBinding Site

Author

Tao, Qing-Feng, Soszynski, Piotr A., Hollenberg, Norman K., and Graves, Steven W.

Abstract

Efforts to study the endogenous sodium pump inhibitor (ESPI) have been complicated by the limited specificity of available assays. We recently developed an assay of [Na,K]ATPase inhibition more sensitive than conventional assays. This enhancement reflects a prereaction step that increases binding affinity of digitalislike molecules to the digitalis receptor. We tested the possibility that this enhanced inhibition is limited to inhibitors acting specifically through the digitalis-binding site. Using both the standard and sensitive [Na,K]ATPase methods, known specific inhibitors of the sodium pump (ouabain, digoxin, bufalin) showed significant increases in the inhibition in the sensitive as compared with the standard [Na,K]ATPase assay (ouabain 34.4 ± 7.3 vs. 8.3 ± 0.5, digoxin 43.2 ± 9.1 vs. 7.2 ± 3.1, bufalin 46.9 ± 5.0 vs. 22.6 ± 1.6). Some proposed candidates for the ESPI, acknowledged to be nonspecific inhibitors, showed no enhancement (oleic acid 36.0 ± 4.5 vs. 34.8 ± 5.6, lysophosphatidyl choline 10.8 ± 3.5 vs. 12.8 ± 5.2, and vanadate 34.3 ± 8.8 vs. 33.8 ± 1.4). Other candidates, whose inhibitory specificity is unknown, including an ESPI from the peritoneal dialysate of patients with renal failure were also studied. The ESPI showed enhanced inhibition (24.1 ± 4.9 vs. 5.3 ± 2.0). These studies suggest that the sensitive assay in conjunction with a standard [Na,K]ATPase assay may allow the early determination of candidates interacting specifically with the digitalis receptor to inhibit the sodium pump.

Published
1995

Catalog

Books, media, physical & digital resources
See catalog results